Bibliographic record

Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension

Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA…. Diabetes, Obesity and Metabolism 2022

Document identifier: CEI-BR-124
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, Lingvay I, McGowan BM, Oral TK, Rosenstock J, Wadden TA, Wharton S, Yokote K, Kushner RF
Title: Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension
Source: Diabetes, Obesity and Metabolism
Year: 2022
Volume, issue, pages: 24(8):1553–1564
Digital object identifier: 10.1111/dom.14725
PubMed identifier: 35441470
Record type: Journal article
Institute identifier: CEI-BR-124

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

Document	Series
Monograph: Semaglutide	Compound monograph
1 citing document.

§1.3Subject tags

semaglutide withdrawal weight-regain

Compound Evidence Institute · CEI-BR-124 · https://compoundevidence.com/bibliography/wilding2022/ · retrieved 30 July 2026